相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Protein quaternary structure and expression levels contribute to peroxisomal-targeting-sequence-1-mediated peroxisomal import of human soluble epoxide hydrolase
Beubei Luo et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor α
Valerie Y. Ng et al.
DRUG METABOLISM AND DISPOSITION (2007)
Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice
Ayala Luria et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Sequence variation in the soluble epoxide hydrolase gene and subclinical coronary atherosclerosis: Interaction with cigarette smoking
Qi Wei et al.
ATHEROSCLEROSIS (2007)
Beyond vasodilatation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system
Brandon T. Larsen et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
The soluble epoxide hydrolase as a pharmaceutical target for hypertension
Nipavan Chiamvimonvat et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase
Paul D. Jones et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Effects of fenofibrate on lipid metabolism in adipose tissue of rats
Adaliene Versiani Matos Ferreira et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease:: The Atherosclerosis Risk in Communities (ARIC) study
CR Lee et al.
HUMAN MOLECULAR GENETICS (2006)
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: A multicenter, randomized, double-blind, controlled clinical trial
Giuseppe Derosa et al.
CLINICAL THERAPEUTICS (2006)
Endothelium-derived epoxyeicosatrienoic acids and vascular function
I Fleming et al.
HYPERTENSION (2006)
Effects of human soluble epoxide hydrolase polymorphisms on isoprenoid phosphate hydrolysis
AE Enayetallah et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Effects of rosiglitazone and atorvastatin on the expression of genes that control cholesterol homeostasis in differentiating monocytes
G Llaverias et al.
BIOCHEMICAL PHARMACOLOGY (2006)
High-throughput pharmacokinetic method: Cassette dosing in mice associated with minuscule serial bleedings and LC/MS/MS analysis
T Watanabe et al.
ANALYTICA CHIMICA ACTA (2006)
Cytochrome P450 epoxygenases provide a novel mechanism for penile erection
LM Jin et al.
FASEB JOURNAL (2006)
The antiinflammatory effect of laminar flow:: The role of PPARγ, epoxyeicosatrienoic acids, and soluble epoxide hydrolase
Y Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension
JD Imig et al.
HYPERTENSION (2005)
Lipid sulfates and sulfonates are allosteric competitive inhibitors of the N-terminal phosphatase activity of the mammalian soluble epoxide hydrolase
KL Tran et al.
BIOCHEMISTRY (2005)
Soluble epoxide hydrolase is a therapeutic target for acute inflammation
KR Schmelzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Activation of peroxisome proliferator-activated receptor α by substituted urea-derived soluble epoxide hydrolase inhibitors
X Fang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition
CA Argmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Distribution of soluble epoxide hydrolase and of cytochrome P4502C8, 2C9, and 2J2 in human tissues
AE Enayetallah et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2004)
Polymorphism of the soluble epoxide hydrolase is associated with coronary artery calcification in African-American subjects - The Coronary Artery Risk Development in Young Adults (CARDIA) study
M Fornage et al.
CIRCULATION (2004)
Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred
K Sato et al.
JOURNAL OF HUMAN GENETICS (2004)
Polymorphisms in human soluble epoxide hydrolase
BD Przybyla-Zawislak et al.
MOLECULAR PHARMACOLOGY (2003)
The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase
A Cronin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity
JW Newman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Central role of peroxisomes in isoprenoid biosynthesis
WJ Kovacs et al.
PROGRESS IN LIPID RESEARCH (2002)
Divergent effects of selective peroxisome proliferator-activated receptor-γ2 ligands on adipocyte versus osteoblast differentiation
B Lecka-Czernik et al.
ENDOCRINOLOGY (2002)
Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension
JD Imig et al.
HYPERTENSION (2002)
Dual mechanisms of ABCA1 regulation by geranylgeranyl pyrophosphate
XD Gan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Potency of select statin drugs in a new mouse model of hyperlipidemia and atherosclerosis
TP Johnston et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2001)
The CYPP450 arachidonic acid monooxygenases: From cell signaling to blood pressure regulation
JH Capdevila et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation
CJ Sinal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
